Dubai, UAE - January 14, 2026 - Kings Research has published a new study titled “Peripheral Vascular Devices Market Size, Share, Growth & Industry Analysis, 2025-2032”.
The report delivers a comprehensive exploration of market dynamics, including segmentation by product type, application area, end user, and regional outlook, offering strategic insights for medical device manufacturers, healthcare investors, clinicians, and technology innovators evaluating emerging opportunities within the peripheral vascular devices sector.
According to Kings Research, the global peripheral vascular devices market was valued at USD 11.21 billion in 2024 and is projected to grow from USD 11.84 billion in 2025 to USD 18.32 billion by 2032, exhibiting a CAGR of 6.43% during the forecast period. This growth is underpinned by the rising prevalence of peripheral artery disease (PAD), expanding adoption of minimally invasive endovascular procedures, and sustained technological innovation in device design and performance.
Peripheral vascular devices are medical tools and implants used in the diagnosis and treatment of vascular diseases affecting blood vessels outside the heart and brain. These include angioplasty balloons, stents, atherectomy systems, embolic protection devices, and specialty catheters, all of which play vital roles in restoring vessel patency. Many of these delivery technologies are closely aligned with advancements seen in the microcatheters sector, where precision navigation and targeted delivery are central to modern vascular care.
Key Trends Shaping the Market
- Growing Burden of PAD and Vascular Disorders
Market expansion is primarily driven by the increasing prevalence of peripheral artery disease and related vascular conditions. Peripheral artery disease affects more than 200 million adults globally, with prevalence reaching up to 20% among individuals aged 70 years and older.. Risk factors such as diabetes, hypertension, obesity, and aging populations are significantly contributing to a higher global disease burden and greater clinical demand for effective vascular therapies.
Global Burden of Disease (GBD) 2021 research indicates that the number of people living with peripheral artery disease worldwide reached approximately 113.7 million in 2021, reflecting the growing impact of population aging and persistent lifestyle-related risk factors. (Source: pmc.ncbi.nlm.nih.gov)
- Rising Adoption of Minimally Invasive Procedures
Healthcare systems worldwide are shifting toward minimally invasive endovascular procedures because they offer shorter recovery times, fewer complications, and better patient outcomes than open surgery.
The U.S. National Library of Medicine notes that percutaneous transluminal angioplasty (PTA) and stent placement are now widely accepted alternatives to surgical bypass for revascularization of peripheral arteries. It states that “stenting and angioplasty are an acceptable alternative for peripheral vascular disease for suitable indications.”. (Source: ncbi.nlm.nih.gov)
- Expansion of Outpatient Care and ASC Segment
The ambulatory surgical center (ASC) segment is anticipated to grow rapidly in the coming years, mainly due to the growing number of outpatient procedures that leverage less invasive vascular devices and streamlined intervention workflows. This outpatient shift is especially significant for venous procedures, aligning with developments in venous stents, where demand is rising for solutions addressing chronic venous insufficiency and deep vein obstruction.
- Clinical Risk and Need for Effective Intervention
Patients with PAD face higher probabilities of heart attack, stroke, reduced mobility, and limb loss, emphasizing the importance of early detection and effective treatment. This high clinical risk profile is accelerating the adoption of advanced peripheral vascular devices that can restore blood flow, reduce complications, and improve long-term patient outcomes through minimally invasive intervention strategies. (Source: acc.org)
For hospital leaders, vascular surgeons, interventional radiologists, and outpatient care providers, peripheral vascular devices deliver meaningful clinical and operational advantages:
- Clinical Outcomes: Restoring blood flow and reducing vascular occlusion risk improves limb preservation, organ function, and overall patient prognosis.
- Faster Recovery: Minimally invasive procedures shorten hospital stays, accelerate patient recovery, and enable quicker return to daily activities.
- Diagnostic & Treatment Precision: High-accuracy imaging and targeted delivery systems enhance diagnosis and allow more effective, localized treatment.
- Care Accessibility: Compatibility with outpatient and ambulatory surgical centers expands access to vascular care beyond traditional hospital settings.
Regional Outlook
North America: Dominated the market in 2024 with strong healthcare infrastructure, high PAD prevalence, and early adoption of cutting-edge devices.
Asia Pacific: Expected to register strong growth in the years to come, mainly driven by rising disease incidence, expanding healthcare access, and increased capacity for interventional vascular care.
Europe: Projected to witness sustained growth through standardized clinical practices, reimbursement frameworks, and rising preference for endovascular treatment options.
Competitive Landscape
Major companies operating in the peripheral vascular devices market include Medtronic, Abbott, Boston Scientific Corporation, TERUMO CORPORATION, Becton Dickinson (BD), Cook Medical, Cardinal Health, B. Braun SE, W. L. Gore & Associates, Getinge AB, AngioDynamics, Cordis, Merit Medical Systems, Penumbra Inc., and Koninklijke Philips N.V.
Leading players operating in the peripheral vascular devices industry are focusing on technological innovation, portfolio expansion, and procedural efficiency to strengthen their competitive position. Major manufacturers are investing in next-generation stents, drug-coated balloons, atherectomy systems, and specialty catheters to improve deliverability, durability, and clinical outcomes in complex peripheral interventions.
To request a sample or access the full Peripheral Vascular Devices Market Size, Share, Growth & Industry Analysis 2025–2032 report visit: https://www.kingsresearch.com/report/peripheral-vascular-devices-market-3018
About Kings Research
Kings Research is a global research and consulting firm that empowers organizations to navigate emerging markets, assess investment potential, and make evidence-based strategic decisions.
All market data are sourced from Kings Research's proprietary analysis, validated against credible government publications and peer-reviewed research papers. Examples cited in this PR include NCBI (National Center for Biotechnology Information), ACC (American College of Cardiology), and IHME (Institute for Health Metrics and Evaluation).